跳至主要内容
临床试验/EUCTR2004-004835-72-GB
EUCTR2004-004835-72-GB进行中(未招募)不适用

A study to determine the effects of growth hormone (GH) replacement therapy on quality of life and cardiovascualr risk in GH deficient adults - Growth Hormone and Quality of Life (GroH-QoL)

niversity of Birmingham0 个研究点目标入组 200 人开始时间: 2005年2月17日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Aged over 18
  • Able to provide informed consent
  • Severe GH deficiency in adult life
  • No GH replacement for six months
  • Other hormone therapy stable over preceding six months
  • Life expectancy > 15 months
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Active malignant disease
  • Active Cushing's disease or active acromegaly
  • Breast feeding
  • Proliferative diabetic retinopathy
  • Sensitivity to GH or it preservative

研究者

相似试验